Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

COSCIENS Biopharma Inc T.AEZS

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:AEZS - Post by User

Post by Hopeforthebeston Jul 25, 2024 12:15pm
141 Views
Post# 36148175

Re:Oct 8

Re:Oct 8proph said -" Commissioning of the 50L facility happened on schedule by the end of Q1 2024,"

It is not on scheduled as commissioning was to be completed by the of 2023 NOT Q1 2024. Also if they are still fine tuning, commissioning is not completed that is what commsssioning, you first build then you run and then you produce a consistent product and optimize. That is the commssioning process. There are serious problems if they still have to fine tune one quarter later, indicating the can't produce a consistent product for approval, which when that happens, Health Canada could take years not a couple months as they are so backlogged.
If they are having this these type of issues with basically a small scale up we are screwed when they actually try a scale up to a commercial meaningful size.
<< Previous
Bullboard Posts
Next >>